Tamarix gallica extract in treatment of gingivitis

Study of the effectiveness of Tamarix gallica on the treatment of patients with gingivitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190406043175N4

Enrollment

Registered

2021-06-23

Start date

2021-08-21

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis. Chronic gingivitis

Interventions

Intervention 1: Intervention group: mouthwash containing 4% hydroalcoholic extract of Tamarix gallica .For each patient, 10 ml of Tamarix gallica extract two times a day for 2 weeks is administered. T

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Gingivitis patients All of these patients had at least 20 permanent teeth

Exclusion criteria

Exclusion criteria: Need to prescribe antibiotics to treat gingivitis Taking anti-inflammatory drugs during the study period Taking anticoagulants drugs during the study period Pregnancy and breastfeeding

Design outcomes

Primary

Measure	Time frame
Gingivitis index. Timepoint: At baseline, week 1 and week 4 of the trial. Method of measurement: Examination by periodontist with periodontal Williams probe.;Plaque index. Timepoint: At baseline, week 1 and week 4 of the trial. Method of measurement: Examination by periodontist with periodontal Williams probe.;Pocket depth. Timepoint: At baseline, week 1 and week 4 of the trial. Method of measurement: Examination by periodontist with periodontal Williams probe.;Bleeding on probing. Timepoint: At baseline, week 1 and week 4 of the trial. Method of measurement: Examination by periodontist with periodontal Williams probe.	—

Measure

Time frame

Gingivitis index. Timepoint: At baseline, week 1 and week 4 of the trial. Method of measurement: Examination by periodontist with periodontal Williams probe.;Plaque index. Timepoint: At baseline, week 1 and week 4 of the trial. Method of measurement: Examination by periodontist with periodontal Williams probe.;Pocket depth. Timepoint: At baseline, week 1 and week 4 of the trial. Method of measurement: Examination by periodontist with periodontal Williams probe.;Bleeding on probing. Timepoint: At baseline, week 1 and week 4 of the trial. Method of measurement: Examination by periodontist with periodontal Williams probe.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Rakhshandeh

Mashhad University of Medical Sciences

rakhshandehh@mums.ac.ir+98 51 3882 8566

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026